Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
BioGaia AB ( ($SE:BIOG.B) ) has issued an update.
BioGaia is set to release its financial report for the third quarter of 2025 on October 22, 2025. Following the release, CEO Theresa Agnew and CFO Alexander Kotsinas will discuss the report and answer questions in a live audiocast, which indicates the company’s commitment to transparency and stakeholder engagement.
The most recent analyst rating on ($SE:BIOG.B) stock is a Buy with a SEK115.00 price target. To see the full list of analyst forecasts on BioGaia AB stock, see the SE:BIOG.B Stock Forecast page.
More about BioGaia AB
BioGaia is a Swedish company specializing in probiotics, with over 35 years of experience in microbiome research. The company develops, markets, and sells products aimed at improving gut, immune, and oral health, distributing them in over 100 markets globally. BioGaia’s class B shares are listed on the Nasdaq Stockholm Mid Cap segment.
YTD Price Performance: 1.71%
Average Trading Volume: 165,694
Technical Sentiment Signal: Buy
Current Market Cap: SEK10.87B
For detailed information about BIOG.B stock, go to TipRanks’ Stock Analysis page.